All posts by imreal

The Undefeated Tribe, a Crunch Fitness Franchise, Announces a New $11 MM Flagship Gym in San Marcos, TX


The Undefeated Tribe, a Crunch Franchise, announced plans today for a new $11 MM flagship location that will be the most expensive build in the industry. Spanning over 35,000 square feet and two stories on four acres, this 24/7 gym will feature world-class equipment and full Amenities. Set to open in the winter of 2023 with construction set to begin in April 2023, this club will bring over 100 new jobs to San Marcos, TX, and will make a big impact on the local community.

The Crunch Fitness experience fuses fitness with entertainment to make serious exercise fun. Members will enjoy miles of cardio, tons of weights, hot yoga, a Kid’s Club with a movie theater, the Ride Cycle Studio, HIITZone Training®, Personal Training, tanning, and HydroMassage®. Crunch is also known for innovative group fitness programming and will offer a wide range of motivating classes including BodyWeb with TRX®, Zumba®, Cardio Tai Box, Yoga Body Sculpt, Fat Burning Pilates, and more.

“All will be welcome at our new flagship location, and there truly will be something for everyone,” said Crunch Franchisee Tony Hartl, CEO of The Undefeated Tribe. “Our goal is to get people from all walks of life to come in, get their heart rates up, break a sweat, and leave feeling better about themselves.”

The locally-owned and operated Crunch Fitness will be open and staffed 24/7 and will offer memberships starting at $9.99 per month with no contracts. This club will also offer an exclusive limited-time promotion for their founding members. The first 500 members will join for only $1 and get their 1st month free plus get a free 1-hour personal training session and a free gym bag.

You can enter to win a free one-year All-Access membership and lock in your Founding 500 rate at https://info.crunch.com/rate-reservations.

Working at the also promises to be an experience like no other. Crunch Fitness will also hire over 100 individuals to work at the flagship location, who will be dedicated to helping their community within the fitness, wellness, relaxation, and recovery space. Crunch is on the search for managers, group fitness instructors, personal trainers, customer service representatives, facility technicians, and babysitters to join a team that believes in being the best place to work and workout.

If you are interested in Working Hard, Having Fun and Making History, please apply today at epiccrunchjobs.com.

About The Undefeated Tribe

Founded in 2018 by Tony Hartl, The Undefeated Tribe is one of the fastest growing franchises within the Crunch Fitness system. The Company currently operates locations in Texas and Oklahoma, with many more in development. In 2021 The Undefeated Tribe was selected as the Franchise of the Year for the Crunch Fitness system. The Undefeated Tribe was recognized as the top-performing franchise for its unique accomplishments and excellence in business performance, community service, and brand involvement.

Share article on social media or email:

The Evolution and Impact of ePROs in Clinical Trials, Upcoming Webinar Hosted by Xtalks


To avoid increasing health disparities in clinical trials, underserved groups should be included through PRO-specific ethical guidelines for clinical research so that patient-reported outcomes are collected.

This webinar will examine the importance of electronic patient-reported outcomes (ePROs) and how working at pace with methodological rigour led to the development of the Symptom Burden Questionnaire™ (SBQ™), a new ePRO measure which includes 16 symptoms scales, each measuring a different symptom. The featured speakers will also talk about the feasibility trial of non-pharmacological interventions as part of the Therapies for Long COVID (TLC) study.

To avoid increasing health disparities in clinical trials, underserved groups should be included through PRO-specific ethical guidelines for clinical research so that patient-reported outcomes are collected.

Register for this webinar to learn about the impact of ePROs through a unique ePRO measure that is tailored to individual patient needs.

Join Prof. Melanie Calvert, Professor of Outcomes Methodology, University of Birmingham; Dr. Sarah Hughes, Research Fellow, Centre for Patient Reported Outcomes Research (CPROR), Institute of Applied Health Research; Dr. Christel McMullan, Qualitative Research Fellow, Centre for Patient Reported Outcomes Research (CPROR), Institute of Applied Health Research; and Chris Frost, Chief Operations Officer, Aparito, for the live webinar on Thursday, May 4, 2023, at 10am EDT (4pm CEST/EU-Central).

For more information, or to register for this event, visit The Evolution and Impact of ePROs in Clinical Trials.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Enriching High Titer IgG-producing Clones Using Cold-Capture and The Namocell Pala Single Cell Dispenser, Upcoming Webinar Hosted by Xtalks


The process of finding high titer clones typically involves screening of large numbers of clones, making it laborious and time-consuming.

Cloning of Chinese hamster ovary (CHO) cells expressing recombinant antibodies is a crucial step in the development of monoclonal antibody (mAb) therapeutics. It is important to identify clones that produce high yield. However, the heterogeneity of CHO cells can give rise to varied IgG expression among individual cells. Thus, the process of finding high titer clones typically involves screening of large numbers of clones, making it laborious and time-consuming.

Cold-capture is a technique that allows labelling of antibody producing cells with a fluorescent reagent that binds to the antibody molecules when they are transiently present on the cell membrane before release from secretory vesicles. This labelling could enable cell sorting based on the level of fluorescence signal to select higher productivity cells. In this study, the featured speaker sought to test the ability to enrich high titer IgG CHO cell clones by cold-capture, followed by isolation of single cells with the brightest fluorescent signal using the Namocell Pala Single Cell Dispenser — a fully automated dispenser that enables a fast, easy fluorescence and light scatter-based single cell isolation. The speaker will show that their method allowed the identification of clones with an average 3x higher IgG production from the cold-capture labelled cells compared to non-cold-captured cells.

These results suggest that the combination of cold-capture and single cell isolation could be an efficient and economical solution for improving cell line development in recombinant antibody production.

Join this webinar to learn more about the potential of cold-capture-facilitated single cell isolation and cloning to improve the efficiency in identifying high yield clones.

Join Francisco Ramirez, Manager, Application Science, Bio-Techne, for the live webinar on Tuesday, May 2, 2023, at 2pm EDT (11am PDT).

For more information, or to register for this event, visit Enriching High Titer IgG-producing Clones Using Cold-Capture and The Namocell Pala Single Cell Dispenser.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Rimidi Announces Integration with MEDITECH Greenfield, Enabling Better Patient Care


News Image

MEDITECH’s support of SMART-on-FHIR is in line with industry best practices for interoperability, and by integrating with Greenfield, we’re able to offer MEDITECH customers a streamlined experience with patient-generated data and the Rimidi platform.

Rimidi, a leading clinical management platform designed to optimize clinical workflows, enhance patient experiences and achieve quality objectives, today announced the company is now integrated with MEDITECH Greenfield. As a result of the new collaboration, MEDITECH customers are now able to utilize Rimidi’s cloud-based software platform within their existing workflow, further enhancing efforts to support efficient models of care for chronic disease management through Fast Healthcare Interoperability Resources (FHIR) application programming interface (APIs).

The healthcare industry initially adopted FHIR as the protocol of choice for API-based data exchange to enable a seamless transfer of patient health information from multiple data sources. As the industry continues to strive toward a value-based care model, the overall healthcare API market is expected to increase to $309.86 million by 2032, allowing for more enhanced collaboration to enable better patient care.

Rimidi’s integration with MEDITECH allows clinicians to use Rimidi within their existing MEDITECH workflow. Specifically, the integration:

  • Enables MEDITECH users to see remote patient-generated data from connected devices and Patient Reported Outcomes Measures within disease-specific views in the patient chart for efficient chronic disease management.
  • Provides insights and clinical decision support to drive next best steps in care and close gaps versus practice guidelines to optimize outcomes in patients with complex chronic conditions.

“We’re excited to add MEDITECH to our portfolio of Electronic Health Record integration partners,” said Lucienne Ide, MD, PhD, Founder and CEO of Rimidi. “MEDITECH’s support of SMART-on-FHIR is in line with industry best practices for interoperability, and by integrating with Greenfield, we’re able to offer MEDITECH customers a streamlined experience with patient-generated data and the Rimidi platform.”

Dr. Ide will be presenting at the HL7 booth at HIMSS, highlighting Rimidi’s experience implementing their SMART-on-FHIR platform across multiple EHRs, as well as clinical outcomes seen with clients so far. The presentations, FHIR Solutions Showcasing Real-World Implementations, will be held Tuesday, April 18 from 1- 2 p.m. CT and Thursday, April 20 from 1-2 p.m. CT.

For more information on Rimidi and its cloud-based software solutions, visit rimidi.com. To book a meeting with Dr. Ide at HIMSS, please reach out to her directly via LinkedIn, and stop by the HL7 FHIR Booth #138 during the conference.

About Rimidi

Created by doctors, Rimidi’s leading clinical management platform empowers healthcare organizations to optimize clinical workflows, enhance patient experiences and achieve quality objectives. By bringing together clinical decision support, remote patient monitoring and patient reported outcomes in a unified, composable, FHIR-based platform, Rimidi supports a broad range of clinical use cases and institutional priorities across large and small healthcare organizations. For more information, visit rimidi.com and follow us on Twitter and LinkedIn.

Share article on social media or email:



Ideal Option Opens Addiction Medicine Clinic in Bentonville


Ideal Option, a national leader in evidence-based outpatient treatment for addiction to fentanyl, heroin, methamphetamine, alcohol and polysubstance, is now welcoming new patients in Bentonville. The new clinic, located at 907 SE Village Loop, Suite 3, will provide primarily buprenorphine-based medication-assisted treatment with an onsite addiction medicine specialist.

While opioid prescribing and heroin use is on the decrease, overdose deaths continue to increase in Arkansas, largely due to the prevalence of fentanyl in the illicit drug supply.

According to data from the county coroners, the number of fatal drug overdoses in Benton and Washington counties nearly doubled in the past three years — from 42 in 2020 to 74 in 2022.

Fentanyl is regularly mixed with other illicit drugs to make them more addictive, often without the user knowing. Polysubstance use disorder is therefore now the most common diagnosis at Ideal Option. In 2022, over half of all Arkansas patients tested positive for more than one substance at enrollment, and 24% tested positive for three or more substances.

The report does offer hope however, by showing how effective medication-assisted treatment is for reducing substance use. For patients who remained in treatment with Ideal Option during 2022, lab testing shows:

  • 94% less fentanyl use
  • 87% less total opioid use
  • 96% less heroin use
  • 77% less methamphetamine use
  • 90% less cocaine use

The new clinic in Bentonville is Ideal Option’s ninth location in Arkansas and is opening at a time of desperate need for expanded access to evidence-based treatment from experienced providers. Ideal Option has been specializing in addiction medicine using buprenorphine-based medications such as Suboxone® for 11 years and currently operates 89 clinics in 11 states.

“In 2022, Ideal Option helped more than 1,000 patients living in Arkansas get started in recovery,” said Aaron Bunch, community outreach coordinator for Ideal Option. “I am excited to expand our life-saving treatment services to Bentonville and look forward to building relationships within this wonderful community.”

The new Ideal Option clinic in Bentonville is open Monday – Thursday, 7:30 a.m. – 6 p.m. and is located at 907 SE Village Loop, Suite 3, Bentonville, AR 72712.

Most forms of insurance are accepted, including Medicare and Medicaid, and patients can typically get started on treatment for fentanyl, heroin, alcohol or other substances within 1-3 business days.

Patients can make an appointment by calling 1.877.522.1275 or visiting http://www.idealoption.com.

About Ideal Option

Headquartered in Kennewick, Washington, Ideal Option was founded in 2012 and has since helped more than 65,000 patients through a network of 89 office-based medication-assisted treatment (MAT) clinics across 11 states. With a mission to serve under-served communities, Ideal Option accepts most forms of insurance including Medicaid and Medicare. Financial assistance and payment plans are also available.

Ideal Option’s team of medical providers carry certifications in Addiction and Emergency Medicine, Internal, and Family Medicine, among other specialties. The company also employs social workers, caseworkers, counselors, and mental health practitioners. This holistic approach helps drive positive outcomes, including family stability, stable housing, improved overall health, and reduced rates of recidivism.

In all the communities it serves, Ideal Option collaborates with existing stakeholders and providers to improve the continuum of care. This approach includes partnerships with emergency rooms and county jail systems, where individuals with substance use disorder often appear, as well as collaborating with numerous support agencies and municipal programs addressing social needs such as housing, mental health, and nutrition support.

Share article on social media or email:

PredxBio is bending the survival curve for immunotherapy cancer patients with spatially intelligent biology at AACR 2023


PredxBio is Showcasing at AACR 2023

PredxBio is Showcasing at AACR 2023

We are excited to share our latest innovations in unbiased spatial analytics and explainable AI and demonstrate how our platform can be used to extract valuable information from patient disease pathology samples imaged with any technology.

PredxBio, formerly known as SpIntellx, is set to showcase its innovative platform at the 2023 Annual Meeting of the American Association for Cancer Research in Orlando, Florida from April 15-19. The company will present its explainable AI-powered unbiased spatial analytics platform that integrates multimodal data to reveal the hidden circuitries of the tumor microenvironment and expose the complex network biology of cancer. The PredxBio platform has been designed to address the challenges of managing cancer patients with immunotherapy, as it only works about 20% of the time, and commercialized diagnostic tests do not provide the tools to make better decisions. By analyzing complex signals from multiple spatial omics technologies, including spatial proteomics, spatial transcriptomics, and brightfield pathology images, PredxBio aims to improve prediction accuracies and drive personalized therapeutic options not only for PD1/PDL1 inhibitor-based therapies but also for novel bispecific/multi-specific antibody therapeutics, and cutting edge chimeric antigen receptor (CAR)-T cell therapies.

At the AACR Annual Meeting, PredxBio will showcase its latest innovations in unbiased spatial analytics and explainable AI, demonstrating how its platform can extract valuable information from patient disease pathology samples imaged with any technology including brightfield pathology, spatial proteomics and/or spatial transcriptomics. PredxBio will be presenting a scientific poster (#5445) showcasing its work on cell segmentation-free analysis of multiplexed images with unbiased spatial analytics and explainable AI for predicting disease outcomes.

The first step in the current approaches for extracting high-value knowledge from multiplexed datasets is to segment cells accurately. Despite decades of research, this step remains elusive due to imaging artifacts leading to low-quality cell segmentation. Those artifacts may lead to incorrect cell phenotypes, incomplete cell phenotype atlases, and missing rare cell, fusion cell and/or transition cell types. To address these issues, PredxBio will showcase a segmentation-free approach on a challenging, low-resolution hyperplexed imaging mass cytometry dataset of triple negative breast cancer. This approach discovers functional collections of neighboring pixels highly predictive of disease progression and leads to tumor promoting and tumor restraining microdomains and microdomain-specific network biology predictive of disease outcomes.

“We are unraveling the dynamics of the tumor microenvironment by capturing inter- and intra-cellular communications and their distinct spatial configurations, named microdomains. We believe, deriving spatial network biology within each microdomain is key to understanding tumor initiation, progression, and response to therapy thus enabling better patient outcomes” said B. Dusty Majumdar, PhD, CEO of PredxBio.

The PredxBio platform is designed to improve prediction accuracies and drive personalized therapeutic options for selecting optimal therapeutics based on insights into spatial tumor biology of individual patients and their potential outcomes. With the launch of the PredxBio brand, the company is positioned in spatial biology space with the truly unique capability of unravelling the hidden biological circuitries of cancer to predict patient outcomes with 90%+ accuracy.

“The AACR Annual Meeting is an excellent opportunity for PredxBio to showcase our technology and its potential to revolutionize the field of cancer research,” added S. Chakra Chennubhotla, PhD, Chief of AI and COO of PredxBio. “We are excited to share our latest innovations in unbiased spatial analytics and explainable AI and demonstrate how our platform can be used to extract valuable information from patient disease pathology samples imaged with any technology.”

PredxBio will be presenting at the AACR Annual Meeting from April 15-19, 2023, at booth #974. Attendees are encouraged to stop by to see demonstrations of their software platform and to learn more about how PredxBio is working to advance the field of cancer research.

About PredxBio

PredxBio is a Pittsburgh, PA-based scaling-stage company focused on the development of explainable AI-powered spatial analytics software platforms to decipher the complex cancer biology and accelerate innovation in precision pathology and spatial biology. PredxBio’s solutions empower clinicians/researchers to accelerate drug discovery, optimize clinical trials, advance companion diagnostics, personalize therapeutic options, and improve clinical workflows. PredxBio has already completed engagements with early paying customers including pharma partners who are harnessing PredxBio’s solutions to assess treatment response in immunotherapy.

http://www.predxbio.com

Share article on social media or email:

National Ergonomics and Workplace Safety Leader Unveils New Look


News Image

“The best way to ease your worry over experiencing a workplace injury is to work in an environment that values the employee’s safety and ensures their care above all.” -John Groves, CEO of Fit For Work

Fit For Work, the national leader in workplace safety, ergonomics, and injury prevention, has announced a new look, website and tagline for the company’s next phase of growth. Increased alignment as a member of the Confluent Health family further affirms Fit For Work’s commitment of prioritizing employee health and safety with the tagline, “Wherever you are, WE are.”

Fit For Work offers multi-faceted strategic safety solutions and trained staff members to keep workers from all walks of life and in different industries safe on the floor, in the field, and everywhere in between. By anticipating changes in the workplace, Fit For Work prevents employees from ever becoming patients by reducing risk and eliminating injuries.

“The best way to ease your worry over experiencing a workplace injury is to work in an environment that values the employee’s safety and ensures their care above all,” says CEO of Fit For Work, John Groves, DPT. “At Fit For Work, we do whatever it takes to keep every employee safe, so they can do what you’re there to do.”

While the company’s core values and principles will remain the same, Groves explains that the updated creative alignment, employee-centric tagline, and website relaunch are significant steps forward in terms of acknowledging their valued relationship with parent company Confluent Health and the company’s growth associated with it.

“Fit For Work’s nimble and responsive team has and will continue to help create solutions that solve unique challenges in the modern workplace,” says Confluent Health’s CEO, Dr. Larry Benz, PT, DPT, FAPTA. “Our partnership with Fit For Work further expands our ability to offer the best care for our clients and their employees.”

Fit For Work’s rebrand emphasizes Total Worker Health, a NIOSH and CDC initiative that will be emphasized going forward with current and prospective clients. Total Worker Health is defined as policies, programs and practices that integrate protection from work-related safety and health hazards with promotion of injury and illness-prevent efforts to advance worker well-being.

The new website details Fit For Work’s Bundles and Service Stacks, including Early Injury Prevention and Intervention, customized Workspace Ergonomics, simplified Pre-employment Screening and free resources for promoting Workplace Safety. Fit For Work’s proactive approach and commitment to the employee will continue to help clients reduce the risk of workplace injuries and illnesses, enhance productivity and improve overall employee well-being.

###

About Fit For Work:

Fit For Work is a privately held Occupational and Industrial Health practice developed around a model of prevention, ergonomics, and early intervention. Founded in 1998, it For Work has continuously sought to provide large and small employers alike with a non-traditional service model. This preventative model combines focus on three leading indicators to an injury; Early Soreness, Ergonomics and Behaviors resulting in significant decreases in injuries and their associated cost as well as, increased client profitability & productivity. For more information, please visit wellworkforce.com

About Confluent Health:

Confluent Health is a family of physical and occupational therapy companies. We are transforming healthcare by strengthening private practices, developing highly effective clinicians, innovating new services and technology to improve the quality of care for patients, and lowering costs via more effective treatment, workplace wellness, and injury prevention. For more information, visit goconfluent.com or find us on Facebook at @confluenthealth

Source: National Institute for Occupational Safety and Health , Total Worker Health® is a registered trademark of the U.S. Department of Health and Human Services.

Share article on social media or email:

New Book of Daily Devotionals Hopes to Offer Healing for Those Struggling with Addiction


News Image

“Recovery is a lifelong journey, and no one should have to walk it alone,” said Meads. “Through this devotional, I desire to show readers struggling with addiction that they will find strength, encouragement, and the support needed to keep moving forward.”

Addiction is argued to be a debilitating struggle that affects millions of people worldwide. In some cases, individuals who struggle with addiction may turn to faith for strength and guidance, but finding the right resources may be challenging. Hoping to offer support, author Wayne Meads Jr. is excited to release his new book, “180 Degrees in 180 Days.”

Meads offers a daily devotional that encourages readers to discover freedom from active addiction or merely help redefine what they may need to live a fulfilling life. The timeline in the book attempts to coincide with the readers’ physical and mental pain and emotional turmoil from the first days of recovery until the 180th day. Additionally, it touches on the pain and shame one may feel at the beginning of treatment and progresses to the success of a new beginning.

“Addiction is a complex issue, as it can be easy to feel alone and overwhelmed in the struggle,” said Meads. “As someone who has battled it myself, I wanted to create a resource that would help others find hope and healing through faith.”

Meads hopes by committing 15 minutes a day to read and incorporate his suggestion, the reader’s recovery may be built on solid ground that emphasizes the importance of a relationship with God along with the 12-step program.

“Recovery is a lifelong journey, and no one should have to walk it alone,” said Meads. “Through this devotional, I desire to show readers struggling with addiction that they will find strength, encouragement, and the support needed to keep moving forward. God has a plan and a purpose for everyone’s life outside of addiction that they could never imagine.”

“180 Degrees in 180 Days”

By Taylor Moralez

ISBN: 9781665737913 (softcover); 9781665737906 (electronic)

Available at Archway Publishing, Amazon and Barnes & Noble

About the author

Wayne Meads Jr. continues to preach the message of Jesus Christ as a Salvationist and inspiring those fighting addiction to embrace all that the Bible along with a 12-step program has to offer. For 25 years Wayne has had to battle his own addictions and understands the vicious cycle that seems to never end. After years of sobriety, he still believes that the incorporation of a Christ centered life along with the fellowship of a 12-step program maximizes one’s efforts to fulfill a life of freedom from active addiction. Today he continues to preach the gospel as well as attend meetings and shares his newfound life with his wife Claudia and two kids Micah and Lilah. To learn more, please visit https://www.archwaypublishing.com/en/bookstore/bookdetails/847703-180-degrees-in-180-days.

General Inquiries:            

LAVIDGE – Phoenix                        

Taylor Moralez

Tmoralez@lavidge.com

Share article on social media or email:

Ohio Reproductive Medicine Becomes the Only Fertility Center in Columbus to Be Recognized in Newsweek Magazine’s 2023 America’s Best Fertility Clinics Report


Columbus, OH

Ohio Reproductive Medicine

“This national recognition is a proud healthcare moment for the city of Columbus, a testament to our scientific innovation, and a wonderful acknowledgment of our team’s dedication to positively impacting the lives of those who wish to build a family.” – Grant Schmidt, MD, PhD

Ohio Reproductive Medicine (ORM), the first-ever fertility center in Columbus, is pleased to announce that it has been recognized for outstanding care in Newsweek Magazine’s 2023 America’s Best Fertility Clinics report.

Ohio Reproductive Medicine is the only fertility center in Columbus to be recognized – and one of only two IVF clinics to be acknowledged in Ohio.

Comprised of four award-winning reproductive endocrinologists, high live birth rates, and a history of success in treating all patients regardless of sexual orientation, gender identity, or marital status – Ohio Reproductive Medicine was ranked within the top 100 fertility clinics in the United States.

View the complete America’s Best Fertility Clinics report by Newsweek.

Newsweek’s ranking is based on a combination of objective metrics and national survey results of over 3,000 infertility specialists, obstetricians, and gynecologists who refer patients to fertility clinics. These assessments and recommendations were utilized alongside key performance indicator metrics for assisted reproductive technology (ART) – including clinic accreditations, patient reviews, and more.

“Our mission and passion are as strong as ever,” said ORM founder and reproductive endocrinologist Grant Schmidt, MD, PhD. “This national recognition is a proud healthcare moment for the city of Columbus, a testament to our scientific innovation, and a wonderful acknowledgment of our team’s dedication to positively impacting the lives of those who wish to build a family.”

Ohio Reproductive Medicine offers a full spectrum of fertility treatments and reproductive services, including intrauterine insemination (IUI), in vitro fertilization (IVF), preimplantation genetic screening (PGT), male infertility testing, LGBTQ+ family building, donor egg IVF, donor sperm options, egg freezing, and more.

In 2021, Ohio Reproductive Medicine opened the doors to its new 15,000 square foot fertility center and IVF laboratory in Columbus.

Earlier that year, ORM announced it had joined Boston IVF’s national fertility treatment network, which recently celebrated 35 years in practice and over 150,000 babies born.

For ORM patients, a significant benefit of the partnership includes gaining access to over 50 Boston IVF fertility doctors, scientists, and experts across its national network – who, alongside ORM reproductive endocrinologists, form a national care committee to review all complex cases, identify essential trends from over 875,000 past IVF cycles, and create effective fertility treatment plans.


  • Follow Ohio Reproductive Medicine on Instagram
  • Follow Ohio Reproductive Medicine on Facebook
  • Follow Ohio Reproductive Medicine on Linkedin
  • Follow Ohio Reproductive Medicine on Twitter
  • Follow Ohio Reproductive Medicine on YouTube

ABOUT OHIO REPRODUCTIVE MEDICINE

For over 35 years, Ohio Reproductive Medicine has helped individuals and couples achieve their dream of building a family. As Central Ohio’s first and largest assisted reproductive technologies (ART) program, ORM continues to pave the way for laboratory excellence, superior clinical care, and high IVF success rates. For more information, please visit Ohio Reproductive Medicine.

Share article on social media or email:



Blueprint Creative Group Expands Behavior Change Capabilities to Address Veteran Suicides, Mental Health Crisis, Maternal Health and Other Public Health Issues


Our expanded behavioral health division enables us to deliver the kind of transformative, evidence-based impact that traditional marketing and public education alone cannot achieve in persuading people to get the help they need when they need it.

Blueprint Creative Group, a leading SBA 8(a) certified strategic communications agency with a health and science communications practice, has expanded its capabilities with a behavioral health division. The company aims to revolutionize how public health agencies and the federal government address critical public health issues such as the mental health crisis, veteran suicide, maternal health outcomes, and opioid addiction.

The new behavioral health division incorporates the latest research and insights from behavioral science and brain function to develop cognitive and behavioral techniques to elicit changes in attitudes, beliefs, and behaviors that promote help-seeking behaviors. The use of social norms messaging is also integrated to shift perceptions of what is normative and acceptable behavior, which can also support health equity programs. With a staff neuroscientist specializing in brain function, behavioral science, and behavior change, Blueprint Creative Group is committed to delivering innovative solutions that address the most pressing health and social challenges of our time.

“Behavior change is at the heart of our health and science communications work. By understanding the science behind behavior change, we can help government and public health agencies be more impactful in addressing the social norms that contribute to negative behaviors and lifestyles,” shares Fabiola Fleuranvil, CEO of Blueprint Creative Group. “Evidence-based approaches are proven to do more than just educate and create awareness and instead, drive measurable behavior change at scale.”

The need for evidence-based approaches is crucial, especially when addressing critical social issues such as veteran suicide. According to a 2020 report from the Department of Veterans Affairs, an average of 17.6 veterans died by suicide each day in 2018, with the majority being 50 years and older. A comprehensive public health approach is necessary to address the underlying causes of veteran suicide and promote help-seeking behaviors. By leveraging behavior change techniques, Blueprint Creative Group’s behavioral health division aims to make a meaningful impact on veteran suicide rates.

Behavior change can also be leveraged for women’s health to improve maternal health outcomes. Maternal mortality rates in the U.S. have been increasing, and according to a report from the Centers for Disease Control and Prevention, approximately 700 women die annually in the U.S. due to pregnancy-related complications. Many of these deaths are preventable, and behavior change can play a significant role in reducing maternal mortality rates. Blueprint Creative Group’s behavioral health division aims to address this issue by developing evidence-based approaches that promote positive health behaviors during women’s reproductive years, at pregnancy and postpartum.

Behavior change can also be used to address the complex mental health crisis and opioid crisis in the country. According to the National Institute of Mental Health, approximately one in five adults in the U.S. experience mental illness in a given year. The opioid crisis has also become a significant public health concern, with approximately 50,000 opioid-related overdose deaths in 2019 alone.

Behavior change and social norms messaging can help to shift perceptions around mental health and substance abuse, reducing the stigma surrounding these issues, and promoting help-seeking behaviors.

“We are committed to delivering innovative solutions that address the most pressing health and social challenges of our time,” says Fleuranvil. “Our expanded behavioral health division enables us to deliver the kind of transformative, evidenced-based impact that traditional marketing and public education alone cannot achieve in persuading people to get the help they need when they need it.”

With a proven track record of success and a team of experts at the forefront of the field, Blueprint Creative Group’s expansion underscores its commitment to using science and creativity to drive positive change in the world.

About Blueprint Creative Group

Founded in 2007, Blueprint Creative Group is an SBA 8(a) certified woman-owned strategic communications agency that supports government and institutions with enterprise-wide communications, public affairs support, health and science communications and multimedia development. As a consultancy, the agency doesn’t approach communications as a standalone function and instead, integrates with strategic planning to ultimately drive business and organizational impact.

To learn more about Blueprint Creative Group’s capabilities, visit blueprintcreativegroup.com.

Share article on social media or email: